What are the precautions with proton pump inhibitor use for reflux disease?
被引:2
|
作者:
Mospan, Cortney M.
论文数: 0引用数: 0
h-index: 0
机构:
E Tennessee State Univ, Bill Gatton Coll Pharm, Pharm Practice, Johnson City, TN 37614 USA
Univ Charitable Pharm, Columbus, OH USAE Tennessee State Univ, Bill Gatton Coll Pharm, Pharm Practice, Johnson City, TN 37614 USA
Mospan, Cortney M.
[1
,2
]
机构:
[1] E Tennessee State Univ, Bill Gatton Coll Pharm, Pharm Practice, Johnson City, TN 37614 USA
[2] Univ Charitable Pharm, Columbus, OH USA
来源:
JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS
|
2015年
/
28卷
/
12期
Gastroesophageal reflux disease (GERD) affects 10% to 20% of the western world's population. Current treatment guidelines recommend proton pump inhibitors (PPIs) as first-line therapy. Although PPIs cause mild adverse reactions, they pose risks, particularly for older adults with comorbidities.
机构:
Hiroshima Prefectural Hosp, Dept Gen Internal Med, Minami Ku, Hiroshima 7348530, JapanHiroshima Prefectural Hosp, Dept Gen Internal Med, Minami Ku, Hiroshima 7348530, Japan
Miyamoto, Masaki
Manabe, Noriaki
论文数: 0引用数: 0
h-index: 0
机构:
Kawasaki Med Sch Med, Dept Gastroenterol, Kurashiki, Okayama, JapanHiroshima Prefectural Hosp, Dept Gen Internal Med, Minami Ku, Hiroshima 7348530, Japan
Manabe, Noriaki
Haruma, Ken
论文数: 0引用数: 0
h-index: 0
机构:
Kawasaki Med Sch Med, Dept Gastroenterol, Kurashiki, Okayama, JapanHiroshima Prefectural Hosp, Dept Gen Internal Med, Minami Ku, Hiroshima 7348530, Japan
机构:
Division of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of MedicineDivision of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine
Makoto Ooi
Tsukasa Ishida
论文数: 0引用数: 0
h-index: 0
机构:
Division of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of MedicineDivision of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine